Synergy CHC Corp. received a delisting notice from Nasdaq on September 11, 2026, following its voluntary Chapter 11 bankruptcy filing on September 4, 2026. Nasdaq cited public interest concerns and the company's inability to sustain listing compliance as reasons for the decision. Trading of the common stock is suspended at the opening of business on September 18, 2026, with a Form 25-NSE to be filed to remove the securities from the exchange. The company does not intend to appeal this determination. Synergy CHC Corp. operates in the healthcare sector, specifically focusing on chronic health conditions.
